Fig. 5

The percent reduction in clinical outcomes for a scenario where plant-based pandemic influenza vaccine begins to be deployed 1, 2 or 3 months after the emergence of the pandemic strain (R0 = 1.3) in Canada combined with the availability of traditional pandemic vaccine beginning at 6 months relative to a scenario with no vaccine available. Results are broken down by season of emergence (A = fall, B = spring), and expected vaccine production levels (for plant-based vaccines)